SA
ADMS logo
Adamas Pharmaceuticals, Inc.(ADMS)
Last print 4 weeks agoAbout this dataData status
$8.22▲0.00 (0.00%)Stale · 4 weeks old
Extended:$8.30+0.08 (+0.97%)

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$2.12
Net Income/Share$-1.63
Operating CF/Share$-1.44
Free CF/Share$-1.44
Cash/Share$2.37
Book Value/Share$-1.42
Tangible Book/Share$-1.42
Equity/Share$-1.42
Interest Debt/Share$4.07
CapEx/Share$0.00
Dividend/Share$0.00
Valuation (TTM)
Market Cap--
Enterprise Value$58.30M
P/E Ratio-5.04P/S Ratio0.00
P/OCF Ratio-5.70
P/FCF Ratio0.00
P/B Ratio-5.78
P/TB Ratio-5.78
EV/Sales0.78
EV/EBITDA-1.35
Graham Valuation
Graham Number--
Graham Net-Net$-2.16
Profitability (TTM)
Earnings Yield-19.86%FCF Yield--ROE225.69%ROIC-49.72%Return on Tangible Assets-47.82%
Dividend (TTM)
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue8.64%
SG&A/Revenue143.49%
R&D/Revenue13.09%
Liquidity & Solvency
Debt/Equity-2.60Debt/Assets1.08
Debt/Market Cap--
Net Debt/EBITDA-1.35
Current Ratio3.20Interest Coverage-3.34xIncome Quality0.88
Efficiency
Days Sales Outstanding46 days
Days Payables Outstanding384 days
Days Inventory1306 days
Receivables Turnover8.01x
Payables Turnover0.95x
Inventory Turnover0.28x
Capital Structure
Tangible Assets-$49.98M
Working Capital$76.87M
Invested Capital$85.12M
Intangibles/Assets0.00%

Refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.